The loss of ACSS2 reduces the tumor burden of hepatocellular carcinomas in mice [7,10]; in mice with ACSS2-positive hepatocellular carcinoma, liver tumors grew faster and were more aggressive [7]. The gene discussed is ACSS2; the disease is neoplasm.